BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31557085)

  • 21. The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE).
    Bhakta N; Liu Q; Ness KK; Baassiri M; Eissa H; Yeo F; Chemaitilly W; Ehrhardt MJ; Bass J; Bishop MW; Shelton K; Lu L; Huang S; Li Z; Caron E; Lanctot J; Howell C; Folse T; Joshi V; Green DM; Mulrooney DA; Armstrong GT; Krull KR; Brinkman TM; Khan RB; Srivastava DK; Hudson MM; Yasui Y; Robison LL
    Lancet; 2017 Dec; 390(10112):2569-2582. PubMed ID: 28890157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study.
    Mulrooney DA; Hyun G; Ness KK; Bhakta N; Pui CH; Ehrhardt MJ; Krull KR; Crom DB; Chemaitilly W; Srivastava DK; Relling MV; Jeha S; Green DM; Yasui Y; Robison LL; Hudson MM
    Lancet Haematol; 2019 Jun; 6(6):e306-e316. PubMed ID: 31078468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis: a prospective case-cohort study.
    Pozza C; Pofi R; Tenuta M; Tarsitano MG; Sbardella E; Fattorini G; Cantisani V; Lenzi A; Isidori AM; Gianfrilli D;
    Hum Reprod; 2019 Aug; 34(8):1389-1403. PubMed ID: 31532522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like factor 3, luteinizing hormone and testosterone in testicular cancer patients: effects of β-hCG and cancer treatment.
    Steggink LC; van Beek AP; Boer H; Meijer C; Lubberts S; Oosting SF; de Jong IJ; van Ginkel RJ; Lefrandt JD; Gietema JA; Nuver J
    Andrology; 2019 Jul; 7(4):441-448. PubMed ID: 30609309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
    Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
    Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy.
    Howell SJ; Radford JA; Adams JE; Smets EM; Warburton R; Shalet SM
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):315-24. PubMed ID: 11589674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention).
    Bandak M; Jørgensen N; Juul A; Lauritsen J; Kreiberg M; Oturai PS; Helge JW; Daugaard G
    BMC Cancer; 2017 Jul; 17(1):461. PubMed ID: 28673265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic Age in Peripheral Blood Among Children, Adolescent, and Adult Survivors of Childhood Cancer.
    Plonski NM; Chen C; Dong Q; Qin N; Song N; Parikh HM; Shelton K; Finch ER; Easton J; Mulder H; Zhang J; Neale G; Walker E; Wang H; Krull K; Ness KK; Hudson MM; Robison LL; Li Q; Williams A; Wang Z
    JAMA Netw Open; 2023 Apr; 6(4):e2310325. PubMed ID: 37115548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a relationship between sex hormones and erectile dysfunction? Results from the Massachusetts Male Aging Study.
    Kupelian V; Shabsigh R; Travison TG; Page ST; Araujo AB; McKinlay JB
    J Urol; 2006 Dec; 176(6 Pt 1):2584-8. PubMed ID: 17085164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical ascertainment of health outcomes among adults treated for childhood cancer.
    Hudson MM; Ness KK; Gurney JG; Mulrooney DA; Chemaitilly W; Krull KR; Green DM; Armstrong GT; Nottage KA; Jones KE; Sklar CA; Srivastava DK; Robison LL
    JAMA; 2013 Jun; 309(22):2371-2381. PubMed ID: 23757085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer.
    Brennemann W; Stoffel-Wagner B; Helmers A; Mezger J; Jäger N; Klingmüller D
    J Urol; 1997 Sep; 158(3 Pt 1):844-50. PubMed ID: 9258096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localized irradiation of testes with carcinoma in situ: effects on Leydig cell function and eradication of malignant germ cells in 20 patients.
    Giwercman A; von der Maase H; Berthelsen JG; Rørth M; Bertelsen A; Skakkebaek NE
    J Clin Endocrinol Metab; 1991 Sep; 73(3):596-603. PubMed ID: 1908483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Features of the metabolic syndrome in late adolescence are associated with impaired testicular function at 20 years of age.
    Hart RJ; Doherty DA; Mori TA; Adams LA; Huang RC; Minaee N; Handelsman DJ; McLachlan R; Norman RJ; Dickinson JE; Olynyk JK; Beilin LJ
    Hum Reprod; 2019 Mar; 34(3):389-402. PubMed ID: 30576537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gonadal function after multimodality treatment in men with testicular germ cell cancer.
    Palmieri G; Lotrecchiano G; Ricci G; Spiezia R; Lombardi G; Bianco AR; Torino G
    Eur J Endocrinol; 1996 Apr; 134(4):431-6. PubMed ID: 8640293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
    Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproductive hormones and metabolic syndrome in 24 testicular cancer survivors and their biological brothers.
    Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Oturai PS; Mortensen J; Hojman P; Helge JW; Daugaard G
    Andrology; 2017 Jul; 5(4):718-724. PubMed ID: 28598554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors.
    Sprauten M; Brydøy M; Haugnes HS; Cvancarova M; Bjøro T; Bjerner J; Fosså SD; Oldenburg J
    J Clin Oncol; 2014 Feb; 32(6):571-8. PubMed ID: 24419125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrocardiographic abnormalities and mortality in aging survivors of childhood cancer: A report from the St Jude Lifetime Cohort Study.
    Mulrooney DA; Soliman EZ; Ehrhardt MJ; Lu L; Duprez DA; Luepker RV; Armstrong GT; Joshi VM; Green DM; Srivastava D; Krasin MJ; Morris GS; Robison LL; Hudson MM; Ness KK
    Am Heart J; 2017 Jul; 189():19-27. PubMed ID: 28625376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer.
    Nord C; Bjøro T; Ellingsen D; Mykletun A; Dahl O; Klepp O; Bremnes RM; Wist E; Fosså SD
    Eur Urol; 2003 Sep; 44(3):322-8. PubMed ID: 12932930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testicular function after radioiodine therapy for thyroid carcinoma.
    Wichers M; Benz E; Palmedo H; Biersack HJ; Grünwald F; Klingmüller D
    Eur J Nucl Med; 2000 May; 27(5):503-7. PubMed ID: 10853804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.